Synthetic Controls Database

Synthetic Control Database™

Understand your disease of study better at the start for more effective programs in the end.

Synthetic Control Database (SCD) enriches your disease understanding in support of designing and executing your clinical development plan. Built on Medidata’s vast pool of clinical trial data, the SCD visualization tool enables aggregated statistics and insights into subgroup prognosis, correlations between short-term endpoints and long-term response, baseline characteristics for subgroups, common and uncommon adverse events, and much more.

SCD™ helps you answer clinical questions about a disease, and design the right trial around it.

Why Synthetic Control Database™?

Unrivaled Patient Data, Unprecedented Ease

Get access to data assets from more than 17,000 studies and 4 million trial subjects, all cleaned, standardized, de-identified, and aggregated. Save time and effort with web-based visualization tools that provide pre-populated analyses, such as summary statistics and exploratory evaluations.

More Prognostic and Predictive Power

Identify prognostic factors to indicate an appropriate disease course and refine enrollment criteria of a future study accordingly, reducing the patient population required for the trial to meet endpoints. Identifying predictive characteristics — through analysis of safety and efficacy outcome variables standardized within the database — will enhance your study efficiency and risk-benefit ratio.

Safety and Pharmacovigilance

Interpreting safety events is less complex and less cloudy with access to this unique data source and visualization tool. Its large sample size, acquired by combining data across multiple historical trials, allows you to detect adverse event rate estimates more precisely.

Discover the power of the unified platform enhanced by pioneering analytics.